Anaemia is a well-known complication of chronic kidney disease (CKD) and can significantly impact on a patient's quality of life if it is not managed appropriately. Studies have shown an increased prevalence from stage 3B CKD onwards (Stevens et al, 2007) and 1:5 people with diabetes and ...
chronic kidney diseaseESAiron deficiencyiron therapyBackground Knowledge on anaemia management in non-dialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement. Methods We prospectively evaluated ...
What is New and Conclusion Heme iron polypeptide does not appear to confer benefit over traditional iron supplementation among patients with anaemia of CKD and is more expensive. 展开 关键词: anaemia chronic kidney disease heme iron heme iron polypeptide oral iron ...
Differentiating Factors Between Erythropoiesis-Stimulating Agents: An Update to Selection for Anaemia of Chronic Kidney Disease Erythropoiesis-stimulating agents (ESAs) have become a hallmark of anaemia therapy in patients with chronic kidney disease (CKD). Although different ESAs a... H??rl,H Walter...
Background and Aims Anaemia is a common complication in patients with chronic kidney disease (CKD). Prevalence of anaemia increases with CKD severity and ranges from 17% in patients with stage 3 disease to over 50% in patients with stage 5 CKD who are not on dialysis. Anaemia of CKD is ...
Introduction Hepcidin appears to be an emerging biomarker for anaemia in kidney damage in Chronic Kidney Disease (CKD). Aim: To evaluate serum hepcidin level for its potential role in anaemia of CKD. Materials and Methods: A cross-sectional study was done in 60 subjects. Out of 60 subjects,...
In India, the prevalence of chronic kidney disease (CKD), ranges from 0.79 % to 1.4 %. S... M Sarkari,M Mittal,AK Rai - 《Journal of Evolution of Medical & Dental Sciences》 被引量: 0发表: 2021年 Clinical Research of Jianpiyishen Yin's Effect on Chronic Renal Failure Patients' ...
Correction of iron deficiency anaemia using IV CosmoFer in CKD patients with asthma: a prospective study Abstract Intravenous (IV) iron is commonly used for correcting iron deficiency anaemia (IDA) in patients with chronic kidney disease (CKD). There remains a... A Syed,S Bhandari - 《Qjm An...
Anaemia in CKD 5D Introduction and Aims:Peginesatide is a once-monthly, peptide-based erythropoiesis-stimulating agent (ESA) approved in the US for treatment of anemia due to chronic kidney disease (CKD) in adult patients (pts) on dialysis. Peginesatide d... A Mikhail,M Kaplan,I Macdougall...
Intravenous iron supplementation in the anaemia of renal and cardiac failure—a double-edged sword? The anaemia of chronic kidney disease (CKD) is efficiently corrected with a combination of recombinant erythropoietin (rhEPO) and intravenous iron suppleme... S Itzchak - 《Nephrol Dial Transplant》 ...